Skip to main content
Top
Published in: Journal of Nephrology 5/2019

01-10-2019 | Chronic Kidney Disease | Review

Incremental hemodialysis, a valuable option for the frail elderly patient

Authors: Carlo Basile, Francesco Gaetano Casino, Filippo Aucella

Published in: Journal of Nephrology | Issue 5/2019

Login to get access

Abstract

Management of older people on dialysis requires focus on the wider aspects of aging as well as dialysis. Recognition and assessment of frailty is vital in changing our approach in elderly patients. Current guidelines in dialysis have a limited evidence base across all age group, but particularly the elderly. We need to focus on new priorities of care when we design guidelines “for people not diseases”. Patient-centered goal-directed therapy, arising from shared decision-making between physician and patient, should allow adaption of the dialysis regime. Hemodialysis (HD) in the older age group can be complicated by intradialytic hypotension, prolonged time to recovery, and access-related problems. There is increasing evidence relating to the harm associated with the delivery of standard thrice-weekly HD. Incremental HD has a lower burden of treatment. There appears to be no adverse clinical effects during the first years of dialysis in presence of a significant residual kidney function. The advantages of incremental HD might be particularly important for elderly patients with short life expectancy. There is a need for more research into specific topics such as the assessment of the course of frailty with progression of chronic kidney disease and after dialysis initiation, the choice of dialysis modality impacting on the trajectory of frailty, the timing of dialysis initiation impacting on frailty or on other outcomes. In conclusion, understanding each individual’s goals of care in the context of his or her life experience is particularly important in the elderly, when overall life expectancy is relatively short, and life experience or quality of life may be the priority.
Literature
2.
go back to reference Orimo H, Ito H, Suzuki T et al (2006) Reviewing the definition of “elderly”. Geriatrics Gerontol Int 6:149–158CrossRef Orimo H, Ito H, Suzuki T et al (2006) Reviewing the definition of “elderly”. Geriatrics Gerontol Int 6:149–158CrossRef
3.
go back to reference Centers for Disease Control and Prevention (2003) Public health and aging: trends in aging—United States and worldwide. JAMA 289:1371–1373CrossRef Centers for Disease Control and Prevention (2003) Public health and aging: trends in aging—United States and worldwide. JAMA 289:1371–1373CrossRef
4.
go back to reference Coresh J, Selvin E, Stevens LA et al (2007) Prevalence of chronic kidney disease in the United States. JAMA 298:2038–2047CrossRefPubMed Coresh J, Selvin E, Stevens LA et al (2007) Prevalence of chronic kidney disease in the United States. JAMA 298:2038–2047CrossRefPubMed
6.
go back to reference Arora P, Vasa P, Brenner D et al (2013) Prevalence estimates of chronic kidney disease in Canada: results of a nationally representative survey. CMAJ 185:E417–E423CrossRefPubMedPubMedCentral Arora P, Vasa P, Brenner D et al (2013) Prevalence estimates of chronic kidney disease in Canada: results of a nationally representative survey. CMAJ 185:E417–E423CrossRefPubMedPubMedCentral
7.
go back to reference Bash LD, Astor BC, Coresh J (2010) Risk of incident ESRD: a comprehensive look at cardiovascular risk factors and 17 years of follow-up in the atherosclerosis risk in communities (ARIC) study. Am J Kidney Dis 55:31–41CrossRefPubMed Bash LD, Astor BC, Coresh J (2010) Risk of incident ESRD: a comprehensive look at cardiovascular risk factors and 17 years of follow-up in the atherosclerosis risk in communities (ARIC) study. Am J Kidney Dis 55:31–41CrossRefPubMed
8.
go back to reference Gansevoort RT, Matsushita K, van der Velde M et al (2011) Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int 80:93–104CrossRefPubMedPubMedCentral Gansevoort RT, Matsushita K, van der Velde M et al (2011) Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int 80:93–104CrossRefPubMedPubMedCentral
10.
go back to reference Anderson S, Halter JB, Hazzard WR et al (2009) Prediction, progression, and outcomes of chronic kidney disease in older adults. J Am Soc Nephrol 20:1199–1209CrossRefPubMed Anderson S, Halter JB, Hazzard WR et al (2009) Prediction, progression, and outcomes of chronic kidney disease in older adults. J Am Soc Nephrol 20:1199–1209CrossRefPubMed
12.
go back to reference United States Renal Data System (2014) Annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. Incidence, prevalence, patient characteristics, and treatment modalities. Am J Kidney Dis 63(Suppl 1):e215–e228 United States Renal Data System (2014) Annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. Incidence, prevalence, patient characteristics, and treatment modalities. Am J Kidney Dis 63(Suppl 1):e215–e228
14.
go back to reference Lattanzio F, Corsonello A, Abbatecola AM et al (2012) Relationship between renal function and physical performance in elderly hospitalized patients. Rejuvenation Res 15:545–552CrossRefPubMedPubMedCentral Lattanzio F, Corsonello A, Abbatecola AM et al (2012) Relationship between renal function and physical performance in elderly hospitalized patients. Rejuvenation Res 15:545–552CrossRefPubMedPubMedCentral
15.
go back to reference Corsonello A, Fusco S, Bustacchini S et al (2016) Special considerations for the treatment of chronic kidney disease in the elderly. Expert Rev Clin Pharmacol 9:727–737CrossRefPubMed Corsonello A, Fusco S, Bustacchini S et al (2016) Special considerations for the treatment of chronic kidney disease in the elderly. Expert Rev Clin Pharmacol 9:727–737CrossRefPubMed
16.
go back to reference Walker SR, Gill K, Macdonald K et al (2013) Association of frailty and physical function in patients with non-dialysis CKD: a systematic review. BMC Nephrol 14:228CrossRefPubMedPubMedCentral Walker SR, Gill K, Macdonald K et al (2013) Association of frailty and physical function in patients with non-dialysis CKD: a systematic review. BMC Nephrol 14:228CrossRefPubMedPubMedCentral
17.
go back to reference Fraser SD, Roderick PJ, May CR et al (2015) The burden of comorbidity in people with chronic kidney disease stage 3: a cohort study. BMC Nephrol 16:193CrossRefPubMedPubMedCentral Fraser SD, Roderick PJ, May CR et al (2015) The burden of comorbidity in people with chronic kidney disease stage 3: a cohort study. BMC Nephrol 16:193CrossRefPubMedPubMedCentral
18.
go back to reference Formiga F, Ferrer A, Sanz H et al (2013) Patterns of comorbidity and multimorbidity in the oldest old: the Octabaix study. Eur J Intern Med 24:40–44CrossRefPubMed Formiga F, Ferrer A, Sanz H et al (2013) Patterns of comorbidity and multimorbidity in the oldest old: the Octabaix study. Eur J Intern Med 24:40–44CrossRefPubMed
19.
go back to reference Clegg A, Young J, Iliff S et al (2013) Frailty in elderly people. Lancet 381:752–762CrossRef Clegg A, Young J, Iliff S et al (2013) Frailty in elderly people. Lancet 381:752–762CrossRef
20.
go back to reference Kojima G (2017) Prevalence of frailty in end-stage renal disease: a systematic review and meta-analysis. Int Urol Nephrol 49:1989–1997CrossRefPubMed Kojima G (2017) Prevalence of frailty in end-stage renal disease: a systematic review and meta-analysis. Int Urol Nephrol 49:1989–1997CrossRefPubMed
21.
go back to reference Musso CG, Jauregui J, Macías-Núñez J (2015) Frailty phenotype and chronic kidney disease: a review of the literature. Int Urol Nephrol 47:1801–1807CrossRefPubMed Musso CG, Jauregui J, Macías-Núñez J (2015) Frailty phenotype and chronic kidney disease: a review of the literature. Int Urol Nephrol 47:1801–1807CrossRefPubMed
22.
go back to reference Johansen KL, Chertow GM, Jin C et al (2007) Significance of frailty among dialysis patients. J Am Soc Nephrol 18:2960–2967CrossRefPubMed Johansen KL, Chertow GM, Jin C et al (2007) Significance of frailty among dialysis patients. J Am Soc Nephrol 18:2960–2967CrossRefPubMed
23.
24.
go back to reference Fried LP, Hadley EC, Walston JD et al (2005) From bedside to bench: research agenda for frailty. Sci Aging Knowl Environ 31:24 Fried LP, Hadley EC, Walston JD et al (2005) From bedside to bench: research agenda for frailty. Sci Aging Knowl Environ 31:24
25.
go back to reference Swidler M (2013) Considerations in starting a patient with advanced frailty on dialysis: complex biology meets challenging ethics. Clin J Am Soc Nephrol 8:1421–1428CrossRefPubMedPubMedCentral Swidler M (2013) Considerations in starting a patient with advanced frailty on dialysis: complex biology meets challenging ethics. Clin J Am Soc Nephrol 8:1421–1428CrossRefPubMedPubMedCentral
26.
go back to reference Farrington K, Covic A, Aucella F et al (2016) ERBP guideline development group. Clinical Practice Guideline on management of older patients with chronic kidney disease stage 3b or higher (eGFR < 45 mL/min/173 m2). Nephrol Dial Transplant 31(Suppl 2):ii1–ii66CrossRefPubMed Farrington K, Covic A, Aucella F et al (2016) ERBP guideline development group. Clinical Practice Guideline on management of older patients with chronic kidney disease stage 3b or higher (eGFR < 45 mL/min/173 m2). Nephrol Dial Transplant 31(Suppl 2):ii1–ii66CrossRefPubMed
27.
go back to reference O’Hare AM, Choi AI, Bertenthal D et al (2007) Age affects outcomes in chronic kidney disease. J Am Soc Nephrol 18:2758–2765CrossRefPubMed O’Hare AM, Choi AI, Bertenthal D et al (2007) Age affects outcomes in chronic kidney disease. J Am Soc Nephrol 18:2758–2765CrossRefPubMed
28.
go back to reference Urquhart-Secord R, Craig JC, Hemmelgarn B et al (2016) Patient and caregiver priorities for outcomes in hemodialysis: an international nominal group technique study. Am J Kidney Dis 68:444–454CrossRefPubMed Urquhart-Secord R, Craig JC, Hemmelgarn B et al (2016) Patient and caregiver priorities for outcomes in hemodialysis: an international nominal group technique study. Am J Kidney Dis 68:444–454CrossRefPubMed
29.
go back to reference Aucella F, Stoico L, Cicchella A et al (2012) Comprehensive geriatric assessment in the hemodialysis elderly population. J Nephrol 25(Suppl 19):S85–S89CrossRefPubMed Aucella F, Stoico L, Cicchella A et al (2012) Comprehensive geriatric assessment in the hemodialysis elderly population. J Nephrol 25(Suppl 19):S85–S89CrossRefPubMed
30.
go back to reference Bansal N, Katz R, De Boer IH et al (2015) Development and validation of a model to predict 5-year risk of death without ESRD among older adults with CKD. Clin J Am Soc Nephrol 10:363–371CrossRefPubMedPubMedCentral Bansal N, Katz R, De Boer IH et al (2015) Development and validation of a model to predict 5-year risk of death without ESRD among older adults with CKD. Clin J Am Soc Nephrol 10:363–371CrossRefPubMedPubMedCentral
32.
go back to reference Mandel EI, Bernacki RE, Block SD (2017) Serious illness conversations in ESRD. Clin J Am Soc Nephrol 12:854–863CrossRefPubMed Mandel EI, Bernacki RE, Block SD (2017) Serious illness conversations in ESRD. Clin J Am Soc Nephrol 12:854–863CrossRefPubMed
33.
go back to reference Visser A, Dijkstra GJ, Kuiper D et al (2009) Accepting or declining dialysis: considerations taken into account by elderly patients with end-stage renal disease. J Nephrol 22:794–799PubMed Visser A, Dijkstra GJ, Kuiper D et al (2009) Accepting or declining dialysis: considerations taken into account by elderly patients with end-stage renal disease. J Nephrol 22:794–799PubMed
34.
go back to reference Raghavan D, Holley JL (2016) Conservative care of the elderly CKD patient: a practical guide. Adv Chronic Kidney Dis 23:51–56CrossRefPubMed Raghavan D, Holley JL (2016) Conservative care of the elderly CKD patient: a practical guide. Adv Chronic Kidney Dis 23:51–56CrossRefPubMed
35.
go back to reference Brown EA, Finkelstein FO, Iyasere OU et al (2017) Peritoneal or hemodialysis for the frail elderly patient, the choice of 2 evils? Kidney Int 91:294–303CrossRefPubMed Brown EA, Finkelstein FO, Iyasere OU et al (2017) Peritoneal or hemodialysis for the frail elderly patient, the choice of 2 evils? Kidney Int 91:294–303CrossRefPubMed
38.
go back to reference Kurella TM, Covinsky KE, Chertow GM et al (2009) Functional status of elderly adults before and after initiation of dialysis. N Engl J Med 361:1539–1547CrossRef Kurella TM, Covinsky KE, Chertow GM et al (2009) Functional status of elderly adults before and after initiation of dialysis. N Engl J Med 361:1539–1547CrossRef
39.
go back to reference Jassal SV, Chiu E, Hladunewich M (2009) Loss of independence in patients starting dialysis at 80 years of age or older. N Engl J Med 361:1612–1613CrossRefPubMed Jassal SV, Chiu E, Hladunewich M (2009) Loss of independence in patients starting dialysis at 80 years of age or older. N Engl J Med 361:1612–1613CrossRefPubMed
40.
go back to reference Cooper BA, Branley P, Bulfone L, for the IDEAL Study et al (2010) A randomized, controlled trial of early versus late initiation of dialysis. N Engl J Med 363:609–619CrossRefPubMed Cooper BA, Branley P, Bulfone L, for the IDEAL Study et al (2010) A randomized, controlled trial of early versus late initiation of dialysis. N Engl J Med 363:609–619CrossRefPubMed
41.
42.
go back to reference Corbett RW, Brown EA (2018) Conventional dialysis in the elderly. how lenient should our guidelines be? Semin Dial 31:607–611CrossRefPubMed Corbett RW, Brown EA (2018) Conventional dialysis in the elderly. how lenient should our guidelines be? Semin Dial 31:607–611CrossRefPubMed
43.
go back to reference Wong S, Kreuter W, O’Hare AM (2014) Healthcare intensity at initiation of chronic dialysis among older adults. J Am Soc Nephrol 25:143–149CrossRefPubMed Wong S, Kreuter W, O’Hare AM (2014) Healthcare intensity at initiation of chronic dialysis among older adults. J Am Soc Nephrol 25:143–149CrossRefPubMed
44.
go back to reference Chazot C, Charra B, Van Vo C et al (1999) The Janus-faced aspect of “dry weight”. Nephrol Dial Transplant 14:121–124CrossRefPubMed Chazot C, Charra B, Van Vo C et al (1999) The Janus-faced aspect of “dry weight”. Nephrol Dial Transplant 14:121–124CrossRefPubMed
45.
go back to reference McIntyre CW, Burton JO, Selby NM et al (2008) Hemodialysis-induced cardiac dysfunction is associated with an acute reduction in global and segmental myocardial blood flow. Clin J Am Soc Nephrol 3:19–26CrossRefPubMedPubMedCentral McIntyre CW, Burton JO, Selby NM et al (2008) Hemodialysis-induced cardiac dysfunction is associated with an acute reduction in global and segmental myocardial blood flow. Clin J Am Soc Nephrol 3:19–26CrossRefPubMedPubMedCentral
46.
go back to reference Costa AS, Tiffin-Richards FE, Holschbach B et al (2014) Clinical predictors of individual cognitive fluctuations in patients undergoing hemodialysis. Am J Kidney Dis 64:434–442CrossRefPubMed Costa AS, Tiffin-Richards FE, Holschbach B et al (2014) Clinical predictors of individual cognitive fluctuations in patients undergoing hemodialysis. Am J Kidney Dis 64:434–442CrossRefPubMed
47.
go back to reference Rayner HC, Zepel L, Fuller DS et al (2014) Recovery time, quality of life, and mortality in hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 64:86–94CrossRefPubMedPubMedCentral Rayner HC, Zepel L, Fuller DS et al (2014) Recovery time, quality of life, and mortality in hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 64:86–94CrossRefPubMedPubMedCentral
49.
go back to reference Gotch FA, Sargent JA (1985) A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int 28:526–534CrossRefPubMed Gotch FA, Sargent JA (1985) A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int 28:526–534CrossRefPubMed
50.
go back to reference Eknoyan G, Beck GJ, Cheung AK et al (2002) Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347:2010–2019CrossRefPubMed Eknoyan G, Beck GJ, Cheung AK et al (2002) Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347:2010–2019CrossRefPubMed
52.
go back to reference Tattersall J, Farrington K, Gentile G et al (2018) Is Kt/V useful in elderly dialysis patients? Pro- and Con arguments. Nephrol Dial Transplant 33:742–750CrossRefPubMed Tattersall J, Farrington K, Gentile G et al (2018) Is Kt/V useful in elderly dialysis patients? Pro- and Con arguments. Nephrol Dial Transplant 33:742–750CrossRefPubMed
53.
go back to reference Toth-Manikowski SM, Shafi T (2016) Hemodialysis prescription for incident patients: twice seems nice, but is it incremental? Am J Kidney Dis 68:180–183CrossRefPubMedPubMedCentral Toth-Manikowski SM, Shafi T (2016) Hemodialysis prescription for incident patients: twice seems nice, but is it incremental? Am J Kidney Dis 68:180–183CrossRefPubMedPubMedCentral
54.
go back to reference Lowrie EG, Laird NM, Parker TF et al (1981) Effect of the hemodialysis prescription of patient morbidity: report from the National Cooperative Dialysis Study. N Engl J Med 305:1176–1181CrossRefPubMed Lowrie EG, Laird NM, Parker TF et al (1981) Effect of the hemodialysis prescription of patient morbidity: report from the National Cooperative Dialysis Study. N Engl J Med 305:1176–1181CrossRefPubMed
55.
go back to reference NKF-K/DOQI clinical practice guidelines for hemodialysis adequacy (2001) Update 2000. Am J Kidney Dis 37(Suppl 1):S7–S64 NKF-K/DOQI clinical practice guidelines for hemodialysis adequacy (2001) Update 2000. Am J Kidney Dis 37(Suppl 1):S7–S64
57.
go back to reference Golper TA, Mehrotra R (2015) The intact nephron hypothesis in reverse: an argument to support incremental dialysis. Nephrol Dial Transplant 30:1602–1604CrossRefPubMed Golper TA, Mehrotra R (2015) The intact nephron hypothesis in reverse: an argument to support incremental dialysis. Nephrol Dial Transplant 30:1602–1604CrossRefPubMed
58.
go back to reference Mathew AT, Fishbane S, Obi Y et al (2016) Preservation of residual kidney function in hemodialysis patients: reviving an old concept. Kidney Int 90:262–271CrossRefPubMedPubMedCentral Mathew AT, Fishbane S, Obi Y et al (2016) Preservation of residual kidney function in hemodialysis patients: reviving an old concept. Kidney Int 90:262–271CrossRefPubMedPubMedCentral
59.
go back to reference Rhee CM, Unruh M, Chen J et al (2013) Infrequent dialysis: a new paradigm for hemodialysis initiation. Semin Dial 26:720–727CrossRefPubMed Rhee CM, Unruh M, Chen J et al (2013) Infrequent dialysis: a new paradigm for hemodialysis initiation. Semin Dial 26:720–727CrossRefPubMed
60.
go back to reference Kalantar-Zadeh K, Unruh M, Zager PG et al (2014) Twice-weekly and incremental hemodialysis treatment for initiation of kidney replacement therapy. Am J Kidney Dis 64:181–186CrossRefPubMedPubMedCentral Kalantar-Zadeh K, Unruh M, Zager PG et al (2014) Twice-weekly and incremental hemodialysis treatment for initiation of kidney replacement therapy. Am J Kidney Dis 64:181–186CrossRefPubMedPubMedCentral
61.
62.
go back to reference Fry AC, Singh DK, Chandna SM et al (2007) Relative importance of residual renal function and convection in determining beta-2-microglobulin levels in high-flux haemodialysis and on-line haemodiafiltration. Blood Purif 25:295–302CrossRefPubMed Fry AC, Singh DK, Chandna SM et al (2007) Relative importance of residual renal function and convection in determining beta-2-microglobulin levels in high-flux haemodialysis and on-line haemodiafiltration. Blood Purif 25:295–302CrossRefPubMed
64.
go back to reference Masereeuw R, Mutsaers HA, Toyohara T et al (2014) The kidney and uremic toxin removal: glomerulus or tubule? Semin Nephrol 34:191–208CrossRefPubMed Masereeuw R, Mutsaers HA, Toyohara T et al (2014) The kidney and uremic toxin removal: glomerulus or tubule? Semin Nephrol 34:191–208CrossRefPubMed
65.
go back to reference Leong SC, Sao JN, Taussig A et al (2018) Residual function effectively controls plasma concentrations of secreted solutes in patients on twice weekly hemodialysis. J Am Soc Nephrol 29:1992–1999CrossRefPubMedPubMedCentral Leong SC, Sao JN, Taussig A et al (2018) Residual function effectively controls plasma concentrations of secreted solutes in patients on twice weekly hemodialysis. J Am Soc Nephrol 29:1992–1999CrossRefPubMedPubMedCentral
66.
go back to reference Shafi T, Jaar BG, Plantinga LC et al (2010) Association of residual urine output with mortality, quality of life, and inflammation in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study. Am J Kidney Dis 56:348–358CrossRefPubMedPubMedCentral Shafi T, Jaar BG, Plantinga LC et al (2010) Association of residual urine output with mortality, quality of life, and inflammation in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study. Am J Kidney Dis 56:348–358CrossRefPubMedPubMedCentral
67.
go back to reference van der Wal WM, Noordzij M, Dekker FW et al (2011) Full loss of residual renal function causes higher mortality in dialysis patients; findings from a marginal structural model. Nephrol Dial Transplant 26:2978–2983CrossRefPubMed van der Wal WM, Noordzij M, Dekker FW et al (2011) Full loss of residual renal function causes higher mortality in dialysis patients; findings from a marginal structural model. Nephrol Dial Transplant 26:2978–2983CrossRefPubMed
68.
go back to reference Vilar E, Wellsted D, Chandna SM et al (2009) Residual renal function improves outcome in incremental hemodialysis despite reduced dialysis dose. Nephrol Dial Transplant 24:2502–2510CrossRefPubMed Vilar E, Wellsted D, Chandna SM et al (2009) Residual renal function improves outcome in incremental hemodialysis despite reduced dialysis dose. Nephrol Dial Transplant 24:2502–2510CrossRefPubMed
69.
go back to reference Marquez IO, Tambra S, Luo FJ et al (2011) Contribution of residual renal function to removal of protein-bound solutes in hemodialysis. Clin J Am Soc Nephrol 6:290–296CrossRefPubMedPubMedCentral Marquez IO, Tambra S, Luo FJ et al (2011) Contribution of residual renal function to removal of protein-bound solutes in hemodialysis. Clin J Am Soc Nephrol 6:290–296CrossRefPubMedPubMedCentral
70.
go back to reference Menon MK, Naimark DM, Bargman JM et al (2001) Long-term blood pressure control in a cohort of peritoneal dialysis patients and its association with residual renal function. Nephrol Dial Transplant 16:2207–2213CrossRefPubMed Menon MK, Naimark DM, Bargman JM et al (2001) Long-term blood pressure control in a cohort of peritoneal dialysis patients and its association with residual renal function. Nephrol Dial Transplant 16:2207–2213CrossRefPubMed
71.
go back to reference Wang AY, Wang M, Woo J et al (2002) A novel association between residual renal function and left ventricular hyperthrophy in peritoneal dialysis patients. Kidney Int 62:639–647CrossRefPubMed Wang AY, Wang M, Woo J et al (2002) A novel association between residual renal function and left ventricular hyperthrophy in peritoneal dialysis patients. Kidney Int 62:639–647CrossRefPubMed
73.
go back to reference NKF-K/DOQI clinical practice guidelines for hemodialysis adequacy (2006) Update 2006. Am J Kidney Dis 48(Suppl 1):S2–S90 NKF-K/DOQI clinical practice guidelines for hemodialysis adequacy (2006) Update 2006. Am J Kidney Dis 48(Suppl 1):S2–S90
74.
go back to reference European Best Practice Guidelines Expert Group on Haemodialysis (2002) II.3 Haemodialysis dose and residual renal function (Kr). Nephrol Dial Transplant 17(Suppl 7):S24 European Best Practice Guidelines Expert Group on Haemodialysis (2002) II.3 Haemodialysis dose and residual renal function (Kr). Nephrol Dial Transplant 17(Suppl 7):S24
75.
76.
go back to reference Neri L, Viglino G, Marinangeli G, on behalf of Peritoneal Dialysis Study Group of Italian Society of Nephrology et al (2017) Incremental start to PD as experienced in Italy: results of censuses carried out from 2005 to 2014. J Nephrol 30:593–599CrossRefPubMed Neri L, Viglino G, Marinangeli G, on behalf of Peritoneal Dialysis Study Group of Italian Society of Nephrology et al (2017) Incremental start to PD as experienced in Italy: results of censuses carried out from 2005 to 2014. J Nephrol 30:593–599CrossRefPubMed
77.
go back to reference Basile C, Casino FG, Kalantar-Zadeh K (2017) Is incremental hemodialysis ready to return on the scene? From empiricism to kinetic modelling. J Nephrol 30:521–529CrossRefPubMed Basile C, Casino FG, Kalantar-Zadeh K (2017) Is incremental hemodialysis ready to return on the scene? From empiricism to kinetic modelling. J Nephrol 30:521–529CrossRefPubMed
79.
go back to reference Wong J, Vilar E, Davenport A et al (2015) Incremental haemodialysis. Nephrol Dial Transplant 30:1639–1648CrossRefPubMed Wong J, Vilar E, Davenport A et al (2015) Incremental haemodialysis. Nephrol Dial Transplant 30:1639–1648CrossRefPubMed
80.
go back to reference Lin YF, Huang JW, Wu MS et al (2009) Comparison of residual renal function in patients undergoing twice-weekly versus three-times-weekly haemodialysis. Nephrology 14:59–64CrossRefPubMed Lin YF, Huang JW, Wu MS et al (2009) Comparison of residual renal function in patients undergoing twice-weekly versus three-times-weekly haemodialysis. Nephrology 14:59–64CrossRefPubMed
81.
go back to reference Obi Y, Streja E, Rhee CM et al (2016) Incremental hemodialysis, residual kidney function, and mortality risk in incident dialysis patients: a cohort study. Am J Kidney Dis 68:256–265CrossRefPubMedPubMedCentral Obi Y, Streja E, Rhee CM et al (2016) Incremental hemodialysis, residual kidney function, and mortality risk in incident dialysis patients: a cohort study. Am J Kidney Dis 68:256–265CrossRefPubMedPubMedCentral
82.
go back to reference Singh S, Choi P, Power A et al (2013) Ten-year patient survival and maintenance haemodialysis: association with treatment time and dialysis dose. J Nephrol 26:763–770CrossRefPubMed Singh S, Choi P, Power A et al (2013) Ten-year patient survival and maintenance haemodialysis: association with treatment time and dialysis dose. J Nephrol 26:763–770CrossRefPubMed
83.
go back to reference van Olden RW, van Acker BA, Koomen GC et al (1995) Time course of inulin and creatinine clearance in the interval between two haemodialysis treatments. Nephrol Dial Transplant 10:2274–2280CrossRefPubMed van Olden RW, van Acker BA, Koomen GC et al (1995) Time course of inulin and creatinine clearance in the interval between two haemodialysis treatments. Nephrol Dial Transplant 10:2274–2280CrossRefPubMed
85.
go back to reference Casino FG, Lopez T (1996) The equivalent renal urea clearance: a new parameter to assess dialysis dose. Nephrol Dial Transplant 11:1574–1581CrossRefPubMed Casino FG, Lopez T (1996) The equivalent renal urea clearance: a new parameter to assess dialysis dose. Nephrol Dial Transplant 11:1574–1581CrossRefPubMed
86.
go back to reference Tennekes HA, Sánchez-Bayo F (2013) The molecular basis of simple relationships between exposure concentration and toxic effects with time. Toxicology 309:39–51CrossRefPubMed Tennekes HA, Sánchez-Bayo F (2013) The molecular basis of simple relationships between exposure concentration and toxic effects with time. Toxicology 309:39–51CrossRefPubMed
87.
go back to reference Casino FG, Basile C (2017) The variable target model: a paradigm shift in the incremental haemodialysis prescription. Nephrol Dial Transplant 32:182–190CrossRefPubMed Casino FG, Basile C (2017) The variable target model: a paradigm shift in the incremental haemodialysis prescription. Nephrol Dial Transplant 32:182–190CrossRefPubMed
88.
go back to reference NKF-K/DOQI clinical practice guidelines for hemodialysis adequacy (2015) Update 2015. Am J Kidney Dis 66:884–930CrossRef NKF-K/DOQI clinical practice guidelines for hemodialysis adequacy (2015) Update 2015. Am J Kidney Dis 66:884–930CrossRef
89.
go back to reference Vilar E, Farrington K (2011) Emerging importance of residual renal function in end-stage renal failure. Semin Dial 24:487–494CrossRefPubMed Vilar E, Farrington K (2011) Emerging importance of residual renal function in end-stage renal failure. Semin Dial 24:487–494CrossRefPubMed
90.
go back to reference Casino FG, Basile C (2018) How to set the stage for a full-fledged clinical trial testing “incremental haemodialysis”. Nephrol Dial Transplant 33:1103–1109CrossRefPubMed Casino FG, Basile C (2018) How to set the stage for a full-fledged clinical trial testing “incremental haemodialysis”. Nephrol Dial Transplant 33:1103–1109CrossRefPubMed
91.
go back to reference Casino FG, Basile C (2018) A user-friendly tool for incremental haemodialysis prescription. Nephrol Dial Transplant 33:1046–1053CrossRefPubMed Casino FG, Basile C (2018) A user-friendly tool for incremental haemodialysis prescription. Nephrol Dial Transplant 33:1046–1053CrossRefPubMed
94.
go back to reference Fernández-Lucas M, on behalf of Fundation para la investigation biomedica del Hospital Universitario Ramon y Cajal, Madrid, Spain. Incremental hemodialysis as a starting way of renal replacement therapy. ClinicalTrials.gov Identifier NCT03302546 Fernández-Lucas M, on behalf of Fundation para la investigation biomedica del Hospital Universitario Ramon y Cajal, Madrid, Spain. Incremental hemodialysis as a starting way of renal replacement therapy. ClinicalTrials.gov Identifier NCT03302546
95.
go back to reference Vilar E, on behalf of East and North Hertfordshire NHS Trust, Stevenage, UK. Does incremental initiation of haemodialysis preserve native kidney function? (Incremental HD). ClinicalTrials.gov Identifier NCT03418081 Vilar E, on behalf of East and North Hertfordshire NHS Trust, Stevenage, UK. Does incremental initiation of haemodialysis preserve native kidney function? (Incremental HD). ClinicalTrials.gov Identifier NCT03418081
96.
go back to reference Courivaud C, on behalf of Centre Hospitalier Universitaire de Besancon, France. Quality of life of frail aged patients in incremental hemodialysis (Qualifragilys). ClinicalTrials.gov Identifier NCT03782519 Courivaud C, on behalf of Centre Hospitalier Universitaire de Besancon, France. Quality of life of frail aged patients in incremental hemodialysis (Qualifragilys). ClinicalTrials.gov Identifier NCT03782519
Metadata
Title
Incremental hemodialysis, a valuable option for the frail elderly patient
Authors
Carlo Basile
Francesco Gaetano Casino
Filippo Aucella
Publication date
01-10-2019
Publisher
Springer International Publishing
Published in
Journal of Nephrology / Issue 5/2019
Print ISSN: 1121-8428
Electronic ISSN: 1724-6059
DOI
https://doi.org/10.1007/s40620-019-00611-4

Other articles of this Issue 5/2019

Journal of Nephrology 5/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.